COST-EFFECTIVENESS ASSESSMENT FOR COLOMBIA OF LETROZOLE VS. TAMOXIFEN IN ADJUVANT TREATMENT OF HORMONE RECEPTOR-POSITIVE, POST-MENOPAUSAL EARLY BREAST CANCER WOMEN

被引：0
|
作者：
Gamboa, O. [1 ]
Chicaiza, L. [2 ]
Garcia, M. [2 ]
机构：
[1] Inst Nacl Cancerol, Bogota, Colombia
[2] Univ Nacl Colombia, Bogota, Colombia
来源：
VALUE IN HEALTH | 2009年 / 12卷 / 07期
关键词：
D O I：
10.1016/S1098-3015(10)75347-X
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A496 / A496
页数：1
相关论文
共 50 条
  • [1] Cost-effectiveness of exemestane vs. tamoxifen in post-menopausal women with early breast cancer in Germany
    Braun, S.
    Mittendorf, T.
    Greiner, W.
    Dopatka, J.
    von der Schulenburg, J. M.
    VALUE IN HEALTH, 2007, 10 (06) : A326 - A326
  • [2] Cost-benefit analysis of anastrazol and tamoxifen in adjuvant treatment of hormone receptor-positive, post-menopausal breast cancer
    Gamboa, Oscar
    Diaz, Sandra
    Chicaiza, Liliana
    Garcia, Mario
    BIOMEDICA, 2010, 30 (01): : 46 - 55
  • [3] Adjuvant endocrinal treatment of early hormone receptor-positive breast cancer in the post-menopausal patient
    不详
    GEBURTSHILFE UND FRAUENHEILKUNDE, 2006, 66 (11) : C3 - C15
  • [4] Cost-effectiveness analysis of extended adjuvant endocrine therapy in the treatment of post-menopausal women with hormone receptor positive breast cancer
    Erman, Aysegul
    Nugent, Arlene
    Amir, Eitan
    Coyte, Peter C.
    BREAST CANCER RESEARCH AND TREATMENT, 2014, 145 (02) : 267 - 279
  • [5] Cost-effectiveness analysis of extended adjuvant endocrine therapy in the treatment of post-menopausal women with hormone receptor positive breast cancer
    Aysegul Erman
    Arlene Nugent
    Eitan Amir
    Peter C. Coyte
    Breast Cancer Research and Treatment, 2014, 145 : 267 - 279
  • [6] Cost-effectiveness of letrozole versus tamoxifen as initial adjuvant therapy in hormone receptor-positive postmenopausal women with early-stage breast cancer
    Delea, Thomas E.
    Karnon, Jon
    Sofrygin, Oleg
    Thomas, Simu K.
    Papo, Natalie L.
    Barghout, Victoria
    CLINICAL BREAST CANCER, 2007, 7 (08) : 608 - 618
  • [7] The Cost-Effectiveness of Adjuvant Tamoxifen Treatment of Hormone Receptor-Positive Early Breast Cancer Among Premenopausal and Perimenopausal Ghanaian Women
    Addo, Rebecca
    Haas, Marion
    Goodall, Stephen
    VALUE IN HEALTH REGIONAL ISSUES, 2021, 25 : 196 - 205
  • [8] Cost-effectiveness analysis of letrozole vs. tamoxifen as initial adjuvant therapy in hormone-receptor positive postmenopausal women with early breast cancer:: the Belgian perspective
    Kannon, J.
    Berliere, M.
    Depypere, H.
    Dirix, L.
    Jerusalem, G.
    Neven, P.
    Pandaens, R.
    Lecomte, P.
    BREAST, 2007, 16 : S64 - S65
  • [9] Cost-Effectiveness of Lapatinib plus Letrozole in Post-Menopausal Women with Hormone Receptor- and HER2-Positive Metastatic Breast Cancer
    Delea, Thomas E.
    Hawkes, Carol
    Amonkar, Mayur M.
    Lykopoulos, Konstantinos
    Johnston, Stephen R. D.
    BREAST CARE, 2013, 8 (06) : 429 - 437
  • [10] Cost-effectiveness of letrozole versus tamoxifen as initial adjuvant therapy in hormone-receptor positive postmenopausal women with early breast cancer.
    Delea, T. E.
    Karnon, J.
    Sofrygin, O.
    Thomas, S. K.
    Barghout, V
    BREAST CANCER RESEARCH AND TREATMENT, 2006, 100 : S116 - S117
12345